DANIEL DESTEFANO: Open Payments
NPI 1497488423 · ALEXANDRIA, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,805 in 74 payments from 21 companies in 2025. Trend: 2023 $211 · 2024 $770 · 2025 $1,805
Food & beverage: $1,791Education: $14
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $327 |
| Gilead Sciences, Inc. | 15 | $300 |
| AstraZeneca Pharmaceuticals LP | 5 | $208 |
| Medtronic, Inc. | 2 | $111 |
| Lilly USA, LLC | 4 | $99 |
| ABBVIE INC. | 4 | $97 |
| Amgen Inc. | 5 | $97 |
| ViiV Healthcare Company | 4 | $87 |
| Exact Sciences Corporation | 3 | $76 |
| ALK-Abello, Inc | 3 | $76 |
Products named: BREZTRI, Ozempic, Wegovy, SYMPLICITY G3, Rybelsus, NEFFY, APRETUDE, UBRELVY.
Industry payments across VA — which companies pay providers there.
